FindTrial
Sign In

Evaluation of clinical efficacy of nasal endotracheal intubation in critically ill patients with COVID-19 infection

Evaluation of clinical efficacy of nasal endotracheal intubation in critically ill patients with COVID-19 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069018
Enrollment
Unknown
Registered
2023-03-03
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 infection

Interventions

orotracheal intubation group:N/A
nasotracheal intubation group :N/A

Sponsors

Department of Anesthesiology, Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Retrospective collection of 90 critically ill patients with COVID-19 infection admitted in the respiratory ICU, anesthesia ICU and neurosurgery ICU of Xiangya Second Hospital of Central South University from December 2022 to January 2023, including 45 cases in NTI group and 45 cases in OTI group

Exclusion criteria

Exclusion criteria: ? Incomplete medical record data that cannot be traced; ? Age<18; ? Respiratory failure or hypoxemia caused by diseases other than novel coronavirus infection.

Design outcomes

Primary

MeasureTime frame
the dose of sedative and analgesic muscle relaxants ;—

Secondary

MeasureTime frame
The intubation time, ICU stay time, hospitalization days, tracheotomy rate, intubation/extubation, nursing workload, patient evaluation and other aspects of the two groups.;—

Countries

China

Contacts

Public ContactYan-Ling Zhang

Department of Anesthesiology, Second Xiangya Hospital, Central South University

luoruyi@csu.edu.cn+86 13319606619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026